Form 4: VolitionRx CFO Terig Hughes Receives Restricted Stock Units in Lieu of Cash Compensation

Terig Hughes, CFO of VolitionRx Ltd, was awarded 13,969 restricted stock units (RSUs) on March 1, 2025, in lieu of cash compensation.

Summary

• On March 1, 2025, Terig Hughes, the Chief Financial Officer of VolitionRx Ltd, received 13,969 restricted stock units (RSUs) under the company's 2024 Stock Incentive Plan.
• These RSUs were granted in place of cash compensation.
• The RSUs vest in three installments: 4,657 units on March 1, 2025, 4,656 units on April 1, 2025, and 4,656 units on May 1, 2025.
• The RSUs are also subject to further time-based vesting in a single installment on March 1, 2026, contingent upon continued service.
• Upon vesting and settlement, Hughes will receive common stock shares equal to the number of vested RSUs.
• Following the transaction, Hughes beneficially owns 390,221 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of executive compensation. The use of RSUs instead of cash could be seen as slightly positive for the company's cash position, but it's not a major event.

Positives

• Granting RSUs in lieu of cash compensation can conserve the company's cash reserves.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Stock-based compensation is a common practice in the biotechnology industry to attract and retain talent while managing cash flow, especially for companies in the development stage like VolitionRx.

Comparison to Industry Standards

• Granting RSUs to executives is a standard practice among publicly traded companies, particularly in the biotech sector.
• The vesting schedule of the RSUs (three installments in the first three months, then a final installment a year later) is a fairly typical arrangement to incentivize continued service.
• Comparable companies like Exact Sciences or Guardant Health also utilize stock options and RSUs as part of their executive compensation packages.

Stakeholder Impact

• Shareholders may view the RSU grant as a way to conserve cash, but also as a potential dilution of equity.
• Employees may see this as a positive sign of the company's commitment to its executives.

Key Dates